Background and purpose: In many countries, Alzheimer's disease (AD) has gradually become a common disease in elderly populations. The aim of this study was to analyse trends of mortality caused by AD in the 28 member countries in the European Union (EU) over the last two decades. Methods: We extracted data for AD deaths for the period 1994-2013 in the EU from the Eurostat and World Health Organization database. Age-standardized mortality rates per 100 000 were computed. Joinpoint regression was used to analyse the trends and compute the annual percent change in the EU as a whole and by country. Analyses by gender and by European regions were conducted. Results: Mortality from AD has risen in the EU throughout the study period. Most of the countries showed upward trends, with the sharpest increases in Slovakia, Lithuania and Romania. We recorded statistically significant increases of 4.7% and 6.0% in mortality rates in men and women, respectively, in the whole EU. Several countries showed changing trends during the study period. According to the regional analysis, northern and eastern countries showed the steepest increases, whereas in the latter years mortality has declined in western countries. Conclusions: Our findings provide evidence that AD mortality has increased in the EU, especially in eastern and northern European countries and in the female population. Our results could be a reference for the development of primary prevention policies.
Introduction
Alzheimer's disease (AD) is defined by the World Health Organization as a degenerative cerebral disease of unknown etiology, with characteristic neuropathological and neurochemical features [1] .
With the progressive increase in life expectancy, AD has become an increasing public health issue. In 2013, the Global Burden of Disease Study found that AD was one of the top 50 global causes of years of life lost, which experienced a pronounced increase in the past few years [2] , and it has been estimated that the disease will be the seventh highest cause of death in high-income countries in the year 2030 [3] .
Previous studies described increasing trends in mortality from AD in the USA, where the mortality rate rose from 45.3 per 100 000 in 1999 to 50.0 per 100 000 in 2008 [4] , and in Canada, where the crude mortality rate for men and women increased from 10.1 to 11.5 per 100 000 and 24.4 to 25.4 per 100 000, respectively, between 2004 and 2011 [5] .
However, to date, no studies have been conducted at a European level, using a consistent methodology, estimating significant changes in trends. Therefore, the aim of this study was to analyse trends of mortality caused by AD in the European Union (EU) in the period 1994-2013.
Methods
Data from men and women over 50 years of age from the 28 member countries of the EU in the period 1994-2013 were extracted from the statistical office of the EU (Eurostat) (http://ec.europa.eu/eu rostat/data/database) [6] . The World Health Organization database (http://data.euro.who.int/dmdb/) was used when data were not available [7] , extracting data from Belgium (2000) (2001) (2002) , Denmark (2010), Germany (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) , France (2011) , Croatia (1995 Croatia ( -1998 , the Netherlands (1996 Netherlands ( -2006 , Poland (1999 Poland ( -2004 and Slovakia (1994 Slovakia ( -1995 . Databases were updated in April 2016 and December 2015, respectively. Both databases receive data from each country's statistical authorities and no further analyses are conducted. Thus, we assume that data do not differ substantially and do not have a significant effect on the results.
During the study period, two different revisions (9 th and 10 th revisions) of the International Classification of Diseases (ICD) were used. AD deaths were recorded according to the ICD-9 code 331.0 and ICD-10 code G30.
Estimates of resident population, based on official censuses, were also extracted from the Eurostat database (updated on April 2016) [6] . Due to the study design, no approval by an institutional review board was needed.
The 28 EU member countries and their available data included: Belgium (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) . Unfortunately, data for one or more calendar years were missing from a few countries. No extrapolation was made for missing data. We assumed that trends would not notably vary in those countries with fewer missing data. Conversely, in those countries with more missing data, results could have been affected to a certain extent and should be interpreted carefully.
From the matrices of certified death and resident population, age-standardized mortality rates per 100 000 for each 5-year age group (from 50-54 to ≥85 years) and calendar period for men and women were computed, using the direct method and based on the 2013 European Standard Population.
We also conducted an analysis to assess regional mortality trends, distinguishing four European regions: northern (Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden and UK), southern (Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia and Spain), eastern (Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovakia), and western (Austria, Belgium, France, Germany, Luxembourg and the Netherlands) Europe.
We used the Joinpoint regression software (version 4.2.0.2; Surveillance Research Program, USA National Cancer Institute, Bethesda, MD, USA) to analyse significant changes in mortality trends. This analysis identified inflexion points (called 'joinpoints') at which there was a significant change in the linear slope of the trend [8] . The number and location of significant joinpoints for each country were determined using a log-linear model. We computed the estimated annual percent change (APC) and corresponding 95% confidence intervals, which described the magnitude of change for each of the identified trends. In this model, age-standardized mortality rates were used as the dependent variable and the year of death as the independent variable. In all analyses, a P < 0.05 was regarded as statistically significant.
Results
Between 1994 and 2013, the number of recorded deaths from AD in the EU increased steadily from 41 255 (13 508 men and 27 747 women) to 86 822 (26 974 men and 59 848 women).
The overall age-standardized mortality rate increased from 28.18 to 45.19 per 100 000. In 1994, the highest rate was found in France (20.58 per 100 000) and the lowest in Lithuania (0.43 per 100 000). In 2013, Finland had the highest mortality rate (278.92 per 100 000), whereas the lowest rates were observed in Malta and Latvia (<5 per 100 000) (Table S1 ).
According to our findings, during the 2004-2013 period the entire EU showed a statistically significant increase of 5.6% in mortality rates, with no identifiable joinpoints. Mortality rates rose over the last two decades in 26 countries throughout the EU. Slovakia and Romania had the largest increases (APC, 26.0% and APC, 22.7%, respectively), whereas Luxembourg (APC, 1.2%) and Latvia (APC, 2.8%) showed the smallest increases. Declining trends were only observed in Malta (APC, À4.1%) and Germany (APC, À0.4%).
Trends of mortality from Alzheimer's disease by gender
Age-standardized mortality rates for men are presented in Table S2 . In 1994, the highest rates were observed in France, Spain and Czech Republic (>10 per 100 000), and the lowest in Lithuania, Slovakia, Greece and Hungary (<2 per 100 000). In 2013, Finland had the highest male rates (270.02 per 100 000), whereas the lowest were found in Malta, Greece and Bulgaria (<6 per 100 000).
Throughout the EU, men showed a statistically significant increase in mortality (APC, 4.7%), with no joinpoints observed. Mortality rates between 1994 and 2013 rose in 25 countries. Slovakia, Romania and Lithuania had the largest increases, whereas we observed less pronounced increases for Poland, Greece and Belgium. In contrast, only Germany, Malta and Luxembourg showed an overall downward trend ( Table 1) .
For 11 countries that had an overall upward trend (Hungary, Lithuania, Romania, Greece, Italy, Sweden, Croatia, Portugal, UK, Spain and Denmark), APCs peaked, increasing at a lower rate or decreasing thereafter. For three countries (Austria, Slovakia and Czech Republic), we observed fluctuating mortality trends, with non-significant decreases followed by pronounced increases.
For women, the highest rates in 1994 were recorded in France, Spain and Czech Republic (>14 per 100 000), and the lowest in Slovakia and Lithuania (<1 per 100 000). In 2013, we observed the highest female rate in Finland (>280 per 100 000) and the lowest in Malta, Latvia and Bulgaria (<7 per 100 000) (Table S3) .
Among European women, we recorded a 6.0% steady and statistically significant increase, without identifying any joinpoints. Mortality from AD rose in 26 countries. The most pronounced increases were observed in Slovakia, Romania and Lithuania, whereas Latvia and Luxembourg showed the smallest increases. In Germany rates levelled off and only Malta showed a declining trend (Table 2) .
In 12 countries with an overall upward trend (Slovakia, Romania, Hungary, Sweden, Slovenia, Denmark, France, Italy, Poland, Portugal, Spain and UK), APCs peaked and continued increasing at a lower rate. In Latvia and Luxembourg, after the APC peaked, we observed a declining trend and increases thereafter. Czech Republic, after a decreasing trend, showed the steepest increases in the latter years of the study.
Trends for both men and women are shown graphically in Fig. 1 . Trends were more pronounced in women than in men except for Czech Republic, Finland, Hungary, Latvia, Lithuania, the Netherlands and Romania.
Trends of mortality from Alzheimer's disease by region
Results from the regional mortality trends analysis showed the sharpest increase in northern and eastern Europe. In western Europe we observed an overall slight increase, and in the period 2009-2013 a statistically significant declining trend. During the same period a pronounced increase was recorded in eastern Europe. Rates have levelled off since the mid-2000s in southern countries (Table 3) .
Discussion
The present updated analysis of mortality from AD in the EU showed overall upward trends in both sexes over the past two decades. The largest increases were found in Slovakia, Romania and Lithuania. We observed the highest mortality rates in Finland, with a steady increase over the study period. Mortality rates levelled off or declined for only two countries, i.e. Germany and Malta.
Most of the countries showed increasing mortality trends for both genders. We compared our findings with previous studies. According to the findings of Desesquelles et al. [9] , mortality has been increasing in France since 1985, which is consistent with our results. An Italian study also showed evidence of an upward trend in the period 1985-2003, with the steepest increases in the latter years [10] . We only analysed available data in the 2000s, when we also observed a pronounced increase in mortality rates. In England and Wales, mortality rates experienced an eightfold increase in men and 12-fold increase in women between 1985 and 2004 [11] . According to our findings, the UK (which also included Scotland and Northern Ireland) also showed rising trends for both sexes, especially in women.
Economic development and the improvement of social conditions over the last decades have led to an increase in life expectancy [12] , which might explain the increasing trends in mortality from age-related diseases, especially in eastern countries (Slovakia, Lithuania, Slovenia, Romania and Hungary), where we observed the lowest mortality rates in the 1990s.
Several northern European countries also showed pronounced increasing trends, presumably due not only to the progressive ageing of their population, but also to other factors. Studies have demonstrated that frequencies of the APOE Ɛ4 allele, a well-studied risk factor for AD [13] , are higher in northern countries [14, 15] . Although it might be thought that increasing mortality rates could be attributed to better diagnostics, Hallberg [16] rejected this idea in Sweden, and remarked on the contribution of environmental factors. However, we cannot discount that better diagnostics and increased awareness of the condition by physicians could explain the increase in mortality rates in other countries.
In many countries, the APC peaked in the early years of the study, when most of the countries implemented ICD-10. Previous studies found a 55% increase in recorded deaths from AD when classified by ICD-10 instead of ICD-9 [17] , due to the inclusion of pre-senile dementia and a lax criterion of imputation to any mention of AD [18] , which could be the reason why mortality rates rose in this period. Subsequent smaller increases or declining trends could be attributed to improvements in health services and prevention policies addressing modifiable risk factors. Norton et al. [19] showed that, in Europe, a 10% reduction per decade of the prevalence of seven modifiable risk factors would result in a 9.1% reduction of the prevalence of AD in the future.
In Germany, mortality rates in men declined, whereas in women they levelled off. Surprisingly, its population is one of the oldest in the entire EU, but this was not reflected in rising mortality trends. Previous studies described decreasing trends in dementia prevalence between 2007 and 2009, suggesting that the reason for these trends might be protective factors (better education, economic development) related to the non-war period of the 20 th century [20] . We also hypothesized that, due to the characteristics and progress of the disease, which might lead to other underlying causes of death, mortality from AD has possibly been under-reported [21, 22] .
Cyprus and Malta were the countries with the smallest populations, and we also observed low mortality figures. It must be taken into account that our results, which showed rising and declining trends, respectively, could be affected by the small populations.
It is worth noting that, because of the low rate of recording dementia as the cause of death, mortality data were not useful in exploring geographical variation and time trends [23, 24] . This may have contributed to an underestimation of the true AD mortality observed in this study.
Our findings showed pronounced mortality trends for women in most of the countries. Sex differences in AD have been widely studied and attributed to several factors, including genetic, hormonal and social factors, or the longer life expectancy of women [25, 26] .
When we assessed the regional mortality trends, we observed the largest increases in northern and eastern Europe. In contrast, in the latter study years, in southern Europe mortality rates levelled off and in western Europe a declining trend was observed. We hypothesized that these differences may be due to lifestyle factors (as well as the social and genetic factors previously stated), such as higher adherence to a Mediterranean diet, which has been found to be a protecting factor against developing AD [27] and associated with a lower mortality risk [28] .
This study has several strengths. To our knowledge, this is the first study analysing AD mortality trends in the whole of the EU. Moreover, mortality data were extracted from official databases. Our study also has limitations. The main limitation is the lack of data from some countries. The databases are updated with data from national statistical offices, but in some cases data were not provided for several years. We decided not to extrapolate or impute in order to analyse only official data. Another limitation is the reflection of the condition as an underlying cause of death, but not as a contributing cause of death.
Conclusion
In conclusion, we confirm that mortality from AD has significantly increased in the EU in the last two decades, especially in eastern and northern Europe, and the female population. Consequently, in the upcoming years, the EU will face not only health but also social and economic challenges. Primary prevention policies addressing preventable risk factors are to be recommended. The effect of diagnostics or medical awareness of the condition deserves further analyses.
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